All you need to know about Mounjaro, the antidiabetic injectable also touted as the most powerful weight-loss drug ever
News2023-04-05
2 Views
The availability of the drug in India may cause a major disruption in the Indian diabetes care drugs market which is expected to register a CAGR greater than 3.5 percent between 2022 and 2027. The COVID-19 pandemic has contributed a major increase in the market.
Latest News from Moneycontrol.com
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
